Bioactive Compounds
-
N2897 Levofloxacin hemihydrateSummary: A broad-spectrum third-generation fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV. -
B2212 Moexipril HClSummary: ACE inhibitor -
BA1932 APOBEC3G-IN-1Summary: APOBEC3G-IN-1 (MN136.0185) is a potent inhibitor. -
N2896 Sodium aescinateSummary: A triterpenoid saponin compound that regulates the CARMA3/NF-κB signaling pathway. -
B2203 Candesartan CilexetilTarget: Angiotensin AT2 ReceptorsSummary: Prodrug of the angiotensin II receptor 1 (AT1) antagonist candesartan -
BA1931 EmivirineSummary: Emivirine (MKC-442) is a potent inhibitor of non-nucleoside reverse transcriptases with values of 0.20 and 0.01 μM for dTTP- and dGTP-dependent DNA or RNA polymerase activity, respectively. -
N2895 IsoquercitrinSummary: A natural polyphenolic flavonoid inhibitor of the Wnt/β-catenin pathway. -
B2114 Mitoxantrone HCl2 CitationTarget: Pim|Topoisomerases|USP|HIV IntegrasesSummary: Topoisomerase II inhibitor, anti-neoplastic drug -
BA1930 AurothioglucoseSummary: Aurothioglucose (Goldthioglucose) contains monovalent gold ions and is a potent active site inhibitor of (thioredoxin reductase 1). -
B2103 IdebenoneSummary: synthetic analog of coenzyme Q10 (CoQ10)

